Streetbeat News

Insider Trading

BDTX

DOMO

SCWX

Insider trades were noted in Black Diamond Therapeutics, Domo, and SecureWorks. Black Diamond Therapeutics Director Rajeev Shah acquired 935,850 shares at an average price of $5.00, costing around $4.68 million. Domo Director David Daniel Daniel III acquired 26,400 shares at an average price of $13.54, costing around $357,580. SecureWorks 10% owner Neil Gagnon bought 6,725 shares at an average price of $6.84, costing around $45,967.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 12:52 pm

MRNA

NFLX

ORCL

TSLA

Insiders at Tesla, Moderna, Oracle, and Netflix have recently sold shares. Tesla's CFO sold 3,750 shares, Moderna's Director sold 15,000 shares, Oracle's Chief Accounting Officer sold 5,000 shares, and Netflix's Director sold 46,057 shares. The reasons for these sales are not clear, but they could be preplanned or due to concerns about the companies' prospects or overpricing.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 12:23 pm

HOOK

UPXI

VNCE

WULF

Insiders at TeraWulf Inc. (WULF), HOOKIPA Pharma Inc. (HOOK), Vince Holding Corp. (VNCE), and Upexi, Inc. (UPXI) have been aggressively buying shares. TeraWulf's director acquired 5,488 shares, HOOKIPA's CEO bought 5,000 shares, Vince Holding's director purchased 1,000 shares, and Upexi's CEO bought 79,945 shares. These transactions indicate the insiders' confidence in their respective companies' prospects.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 10:42 am

BDTX

NBTX

NSTG

Several stocks recorded gains in today's pre-market trading session. Nanobiotix S.A. shares jumped 59.3% after entering into a license agreement with Janssen Pharmaceutical. Black Diamond Therapeutics shares gained 15.2% following a large purchase by Director Rajeev Shah. NanoString Technologies shares gained 13.4% after announcing expected Q2 sales of over $44 million. Other stocks recording gains include Novonix Limited, Ferroglobe PLC, Gorilla Technology Group Inc., Recursion Pharmaceuticals, Inc., CS Disco, Inc., and Polestar Automotive Holding UK PLC.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 10:40 am

ACHR

Adam Goldstein, CEO of Archer Aviation, has become the beneficial owner of about 50.1% of the total voting power of the outstanding capital stock as of July 6.

Portfolio Pulse from Charles Gross

July 07, 2023 | 8:53 pm

BDTX

Rajeev Shah, a director at Black Diamond Therapeutics, has purchased 935,850 shares at an average price of $5.00 per share, as reported in a Form 4 filing.

Portfolio Pulse from Charles Gross

July 07, 2023 | 8:46 pm

BICX

CDZI

RZLT

Insiders at BioCorRx Inc. (OTC:BICX), Rezolute, Inc. (NASDAQ:RZLT), and Cadiz Inc. (NASDAQ:CDZI) have recently made significant share purchases. BioCorRx Director Joseph J Galligan acquired 184,780 shares, Rezolute's Chief Medical Officer Brian Kenneth Roberts bought 5,000 shares, and Cadiz's 10% owner Heerema International Group Services SA purchased 200,000 shares. These transactions indicate the insiders' confidence in their respective companies' prospects.

Portfolio Pulse from Lisa Levin

July 07, 2023 | 12:59 pm

AMZN

PINS

TSLA

WMT

Insiders at Tesla, Amazon, Walmart, and Pinterest have recently sold shares. Tesla's SVP, Automotive Xiaotong Zhu sold 2,500 shares, Walmart's Executive Vice President John Rainey sold 8,526 shares, Amazon's CEO Worldwide Amazon Stores Douglas J Herrington sold 4,000 shares, and Pinterest's Director Jeffrey Jordan sold 7,500 shares. The reasons behind these sales are not clear, but they could be due to preplanned sales or concerns about the companies' prospects.

Portfolio Pulse from Lisa Levin

July 07, 2023 | 12:06 pm

BDTX

NVCT

PLCE

Insider trades were noted in three US-listed companies: Children's Place, Inc. (NASDAQ:PLCE), Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), and Nuvectis Pharma, Inc. (NASDAQ:NVCT). The CEO of Children's Place acquired 43,000 shares at an average price of $23.70, costing around $1.02 million. Black Diamond Therapeutics' Director bought 1,000,000 shares at an average price of $5.00, costing around $5 million. Nuvectis Pharma's 10% owner purchased 1,176 shares at an average price of $15.52, costing around $18,252.

Portfolio Pulse from Lisa Levin

July 07, 2023 | 11:19 am

ATVI

Massachusetts Representative Seth Moulton reported a sale of Activision Blizzard (NASDAQ:ATVI) stock valued between $100,001 - $250,000 on July 5, 2023. The sale was revealed in a recent report from the House of Representatives Clerk's Office. Activision Blizzard shares are currently trading down 0.46% at $82.48.

Portfolio Pulse from Benzinga Insights

July 06, 2023 | 3:05 pm